The human gut is known to harbor trillions of microbes (beneficial bacteria) that coexist in synergistic balance forming a unique and dynamic pattern personalized to each individual, called as the gut-biome or microbiome.

 

The concept that insulin resistance and resultant imbalance in glucose/insulin can be caused by changes in the composition of microbiome has been clinically established.

 

Western diets and stressful lifestyle negatively alter the balance of gut-biome (Dysbiosis) which can promote inflammation induced insulin resistance a precursor for pre-diabetes and diabetes.

 

Glucosyn uniquely nourishes the beneficial bacteria, restores the balance of gut-biome and proven to reduce inflammation that can potentially improve insulin resistance, and reduce risk factors for glucose imbalance.